Clinical trial
An Investigation To Determine The Potential Interaction Effect Between GW876008…
NCT00423761 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00423761 |
|---|---|
| Title | An Investigation To Determine The Potential Interaction Effect Between GW876008 And Midazolam. |
| Official title | An Open-Label, Single-Sequence Study to Evaluate the Potential CYP 3A4 Pharmacokinetic Interaction of GW876008 in Healthy Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy Subjects |
| Intervention type | Drug |
| Interventions | midazolam, GW876008 |
| Enrollment | 25 |
| Start date | Dec 1, 2006 |
| First posted | Jan 18, 2007 |
| Last update posted | May 18, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: